OMX30 1 525 0,8%  OMXH25 3 711 0,5%  OMXC20 892 -0,1%  Dow 19 827 0,5%  Nas 5 063 0,2%  EUR 9,5181 -0,3%  USD 8,8846 -0,8%  Olja 55,5 2,3%  Guld 1 193 -1,7% 

Eli Lilly and Aktie

76,80USD -0,04USD -0,05%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Eli Lilly and

2015 2016e 2017e 2018e 2019e
Utdelning 2,00 2,06 2,13 2,19 2,35
Direktavkastning (i %) 2,31 2,76 2,86 2,93 3,16
PE-tal 25,23 21,03 18,39 17,11 15,11
Resultat/aktie 3,43 3,54 4,05 4,35 4,93

Nyheter om Eli Lilly and Co.

ytterligare nyheter

Analyser om Eli Lilly and Co.

ytterligare analyser

Eli Lilly and Peer Group

Bayer 102,50
0,6%
Eli Lilly and 76,80
-0,1%
GlaxoSmithKline 15,47
-0,4%
Merck 62,53
3,6%
Merck 102,70
-0,1%
MorphoSys 48,55
-0,4%
Novartis 70,90
-0,3%
Pfizer 32,10
1,3%
STADA Arzneimittel 48,11
-0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil Eli Lilly and Co.

till bolagsprofilen
Eli Lilly & Co. discovers, develops, manufactures and sells pharmaceutical products. The company operates through the following business segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The Other Pharmaceuticals products include anti-infectives, primarily Vancocin and Ceclor, and other miscellaneous pharmaceutical products and services. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Eli Lilly was founded by Colonel Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Realtidskurs Eli Lilly and Co.

Bid
60,00
USD
Ask
76,81
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Eli Lilly and Co. i USDPUSH CHART

Kurs 76,80 USD -0,04 -0,05 %
Kurstid 21:59:59
Datum 20.01.2017
Öppning 77,11
Gårdagen 76,84
Dagshögsta 77,41
Dagslägsta 76,50
52 v. högsta 83,78
52 v. lägsta 63,70
52 v. perf.
Volym (Antal) 231 338
Börsvärde (SEK) 765,71 Mrd
Börsen
Kurs för 76,80 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 682,34 SEK.

Till aktien Eli Lilly and

Ticker
ISIN US5324571083
Index BX Swiss - USA, S&P 500, S&P 100, NYSE US 100

Eli Lilly and Nyckeltal

Börsvärde i SEK 765,71 Mrd
Free float % 88,36
Antal aktier mio. 1 103,95
Cashflow/aktie i lokal valuta 3,60
Bokvärde/aktie i lokal valuta 14,24
60 dagar vola 40,03
PBV 6,08

Eli Lilly and Historiska kurser

2017-01-19 76,84 210 328
2017-01-18 77,52 174 919
2017-01-17 76,84 302 049
2017-01-13 77,41 308 378
2017-01-12 77,15 475 386

Aktier i samma industri med bättre 1 års perf.

Amylin Pharmaceuticals Inc. 264,9 %
Array BioPharma Inc. 259,2 %
Patheon Inc Restricted Voting Cash Settlement At USD 9.32 A Sh 173,5 %
CV Therapeutics Inc. 169,1 %
Medarex Inc. 123,7 %